<DOC>
	<DOCNO>NCT02940509</DOCNO>
	<brief_summary>The goal research proposal determine intraoperative administrative Ketamine Magnesium laparoscopic gynecologic surgery improve postoperative pain patient chronic opioid therapy management chronic pelvic pain .</brief_summary>
	<brief_title>Ketamine Magnesium Post-operative Pain Control Patients Treated With Opioids</brief_title>
	<detailed_description>In randomize control trial , patient ' postoperative pain score assess score Numeric Rating Score ( NRS ) system . Intraoperative postoperative narcotic usage , nausea score patient ' perception quality recovery via QoR-40 survey also assess . The use intraoperative Ketamine Magnesium predict decrease postoperative pain patient chronic opioid therapy management chronic pelvic pain overall improve patient ' postoperative experience .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>1 . Subjects undergo elective laparoscopic gynecologic surgery 2 . Patients chronic pelvic pain define pain persist 6 month duration localize pelvis , anterior abdominal wall , low back buttock lead functional disability medical care1 3 . Patients require opioids daily &gt; 1 month 4 . Consenting adult age 1880 5 . American Society Anesthesiologists ( ASA ) Physical Status classification II ASA III 1 . Patient refusal 2 . Chronic Kidney disease ( Creatinine &gt; 2 ) 3 . Patients treat methadone 4 . Known allergy adverse effect ketamine magnesium 5 . Patient unable give inform consent 6 . Patient limit English fluency 7 . Uncontrolled hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>